CDBTChina Dasheng Biotechnology Co.

About China Dasheng Biotechnology Co. (CDBT)

China Dasheng Biotechnology Co. (CDBT) is a Shell Companies company headquartered in Arundel, QL, Australia whose shares trade over-the-counter on the Pink tier.

Cycclone, Inc. (Formerly China Dasheng Biotechnology Co. pending FINRA approval). Cycclone, Inc. is an engine, not motor, design and development company with a focus on permanent magnets as the drive force. The Company's focus and objective, which is unproven technology, is to invent, design, and develop engines that can supply power on demand utilizing permanent magnets as a driving force.

Products and services

Cycclone, Inc.’s principal product, which is not sold commercially at this time, is the ongoing development of work to date on designing new engine configurations and associated components to work in conjunction with those engine designs. The Company’s innovative work, prototype manufacturing and in-house precision engineering are planned to redesign how an engine can operate. No services are supplied or sold to clients or customers at this time.

CDBT key facts

Ticker symbol

CDBT

Market tier

Pink

Sector

Financial Services

Industry

Shell Companies

Headquarters

Arundel, QL, Australia

Country of incorporation

US

Year of incorporation

2007

Estimated market cap

$2.41M (as of Apr 11, 2025)

Shares outstanding

40,976,000

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

6/30

Latest filing

Quarterly Report (Dec 31, 2024)

China Dasheng Biotechnology Co. leadership

• Micheal Peter Nugent — CEO, President

Explore more: Shell Companies stocks · Financial Services sector · Pink stocks · OTC stocks starting with C